Atara biotherapeutics to participate in the goldman sachs 45th annual global healthcare conference

Thousand oaks, calif.--(business wire)---- $atra #cart--atara biotherapeutics, inc. (nasdaq: atra), a leader in t-cell immunotherapy, leveraging its novel allogeneic epstein-barr virus (ebv) t-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that pascal touchon, president and chief executive officer and cokey nguyen, ph.d., executive vice president, chief scientific & technical officer, will participate in a fireside chat at the goldman sac.
ATRA Ratings Summary
ATRA Quant Ranking